178 related articles for article (PubMed ID: 25862567)
1. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.
Di Bartolomeo M; Pietrantonio F; Pellegrinelli A; Martinetti A; Mariani L; Daidone MG; Bajetta E; Pelosi G; de Braud F; Floriani I; Miceli R
Gastric Cancer; 2016 Apr; 19(2):412-420. PubMed ID: 25862567
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer].
Guzmán P; Araya J; Villaseca M; Roa I; Melo A; Muñoz S; Roa J
Rev Med Chil; 2006 Aug; 134(8):1002-9. PubMed ID: 17130988
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
6. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of E-cadherin/catenin complex expression in gastric cancer.
Joo YE; Park CS; Kim HS; Choi SK; Rew JS; Kim SJ
J Korean Med Sci; 2000 Dec; 15(6):655-66. PubMed ID: 11194192
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
11. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
Sereno M; De Castro J; Cejas P; García-Cabezas MA; Belda C; Casado E; Feliu J; Gómez C; López M; Barón MG
J Gastrointest Cancer; 2012 Jun; 43(2):181-9. PubMed ID: 21360269
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.
Graziano F; Mandolesi A; Ruzzo A; Bearzi I; Testa E; Arduini F; Silva R; Muretto P; Mari D; Berardi R; Scartozzi M; Lai V; Cascinu S; Magnani M
Tumour Biol; 2004; 25(3):106-10. PubMed ID: 15361706
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract][Full Text] [Related]
14. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
15. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
16. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.
Hou F; Yuan W; Huang J; Qian L; Chen Z; Ge J; Wu S; Chen J; Wang J; Chen Z
Med Oncol; 2012 Dec; 29(4):2691-700. PubMed ID: 22189617
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cell-adhesion molecules in histological variants of papillary thyroid carcinoma.
Andriescu EC; Căruntu ID; Giuşcă SE; Lozneanu L; Ciobanu Apostol DG
Rom J Morphol Embryol; 2018; 59(3):721-727. PubMed ID: 30534810
[TBL] [Abstract][Full Text] [Related]
19. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
20. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
